Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
9441
Video7_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9442
Video3_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9443
Video6_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9444
Video9_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9445
Video13_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9446
DataSheet1_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.pdf
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9447
Video4_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9448
Video5_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9449
Video2_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9450
Video8_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9451
Video14_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9452
Video11_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9453
Video12_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9454
Video1_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9455
Video10_Revealing the nanometric structural changes in myocardial infarction models by time-lapse intravital imaging.MP4
Published 2022“…In the myocardial infarction model, sarcomere shortening decreased from ∼15% (healthy) to ∼8% (diseased) as a result of impaired cardiac function, whereas the distances between sarcomeres increased by 100 nm (from 2.11 to 2.21 μm) in the diastolic state. …”
-
9456
Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
9457
Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
9458
Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
9459
Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”
-
9460
Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx
Published 2024“…</p>Objective<p>The purpose of this study was to analyze the effect of omalizumab on peripheral blood lymphocyte subpopulations in patients with CSU in order to identify potential biomarkers of treatment response.</p>Methods<p>We analyzed 71 patients with CSU [33 under omalizumab and 38 under non-immunomodulatory drugs (treated with antihistamines; NID)] and 50 healthy controls. …”